New Classifications of Five Distinct “Sleep” Profi... ...
A Professional Overview of Hypertension ...
High-speed imaging tracks live brain cell activity...
Drug candidate slows motor neuron disease progress...
Drug candidate slows motor neuron disease progress...
Mark Cuban: A Master Disrupter for American Health...
Superbugs on your plate: How antimicrobial resistance spread...
June 13,2026
Can marijuana cause lung cancer?...
June 12,2026
Standard depression screening could be missing key symptoms ...
June 11,2026
More women are having babies later in life. How to improve y...
June 10,2026
For severe babesiosis, red blood cell exchange is associated...
June 09,2026
Cause or effect? Study answers question about gene linked wi...
June 08,2026
Category
Traditional Medicine
Q & A
Wellness
Drug Discovery
Technology & AI
Clinical Pearl Series
Breakthroughs
Immunology & Rheumatology
Reproduction
Hepatobiliary&Pancreas Surgery
Most Read
Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and SexAverage Ranges Show Normal Pressure On the ArteriesBySheryl Huggins SalomonUpdated on April 21, 2023Medically reviewed byJeffre
Cardiovascular Diseases April 07,2024
Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and SexAverage Ranges Show Normal Pressure On the ArteriesBySheryl Huggins SalomonUpdated on April 21, 2023Medically reviewed byJeffre
Cardiovascular Diseases April 07,2024
Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals has commenced dosing the first patients in its Phase 2a clinical trial for PP405, a novel topical treatment designed to reactivate dormant hair follicle stem cells.
Dermatology August 14,2024
Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals has commenced dosing the first patients in its Phase 2a clinical trial for PP405, a novel topical treatment designed to reactivate dormant hair follicle stem cells.
Dermatology August 14,2024
Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs MeanWhat to Know About Your Blood TypeByNancy LeBrunPublished on September 15, 2023Medically reviewed byAnju Goel, MDYou
Oncology March 17,2024
Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs MeanWhat to Know About Your Blood TypeByNancy LeBrunPublished on September 15, 2023Medically reviewed byAnju Goel, MDYou
Oncology March 17,2024
Today's News
Eye Infections (Updated) | Clinical Medicine...
Announcement of the 2025 Nobel Prize in ...
Dr. Fauci among hundreds who've contract...
Why are young, healthy adults experienci...
Reprogramming Stem Cells Could Cure Type...
More News
Guidance provided for fecal microbiota transplantation in children

Guidance provided for fecal microbiota transplantation in children

by Elana GotkineFor pediatric patients, fecal microbiota transplantation (FMT) is recommended for moderate-to-severe or recurrent Clostridioides difficile infection (CDI), according to a clinical repo
Gastroenterology January 24,2024
Guidance provided for fecal microbiota transplantation in children

Guidance provided for fecal microbiota transplantation in children

by Elana GotkineFor pediatric patients, fecal microbiota transplantation (FMT) is recommended for moderate-to-severe or recurrent Clostridioides difficile infection (CDI), according to a clinical repo
Gastroenterology January 24,2024
Beans beneficial for patients with history of colorectal neoplasia

Beans beneficial for patients with history of colorectal neoplasia

by Elana GotkineAdding a cup of beans to the usual diet enhances the gut microbiome and regulates host markers associated with metabolic obesity and colorectal cancer, according to a study published i
Gastroenterology January 24,2024
Beans beneficial for patients with history of colorectal neoplasia

Beans beneficial for patients with history of colorectal neoplasia

by Elana GotkineAdding a cup of beans to the usual diet enhances the gut microbiome and regulates host markers associated with metabolic obesity and colorectal cancer, according to a study published i
Gastroenterology January 24,2024
Thalidomide cuts recurrent bleeding in small-intestinal angiodysplasia, finds study

Thalidomide cuts recurrent bleeding in small-intestinal angiodysplasia, finds study

by Elana GotkineFor patients with recurrent bleeding due to small-intestinal angiodysplasia (SIA), thalidomide treatment results in a reduction in bleeding, according to a study published in the Nov.
Gastroenterology January 24,2024
Thalidomide cuts recurrent bleeding in small-intestinal angiodysplasia, finds study

Thalidomide cuts recurrent bleeding in small-intestinal angiodysplasia, finds study

by Elana GotkineFor patients with recurrent bleeding due to small-intestinal angiodysplasia (SIA), thalidomide treatment results in a reduction in bleeding, according to a study published in the Nov.
Gastroenterology January 24,2024
Study uncovers how the gut's microbiome boosts immune development

Study uncovers how the gut's microbiome boosts immune development

by Betty Zou,University of TorontoArthur Mortha, left, and Pailin Chiaranunt led new research that unveils new insights into how our resident gut microbes influence immune development. Credit: M
Gastroenterology January 24,2024
Study uncovers how the gut's microbiome boosts immune development

Study uncovers how the gut's microbiome boosts immune development

by Betty Zou,University of TorontoArthur Mortha, left, and Pailin Chiaranunt led new research that unveils new insights into how our resident gut microbes influence immune development. Credit: M
Gastroenterology January 24,2024
Risk assessment after severe complication of liver cirrhosis improved

Risk assessment after severe complication of liver cirrhosis improved

byMedical University of ViennaGraphical Abstract. Credit:Journal of Hepatology(2023). DOI: 10.1016/j.jhep.2023.10.007Approximately half of patients with advanced liver disease have v
Gastroenterology January 24,2024
Risk assessment after severe complication of liver cirrhosis improved

Risk assessment after severe complication of liver cirrhosis improved

byMedical University of ViennaGraphical Abstract. Credit:Journal of Hepatology(2023). DOI: 10.1016/j.jhep.2023.10.007Approximately half of patients with advanced liver disease have v
Gastroenterology January 24,2024
Researchers find gut microbes can affect COVID vaccine response

Researchers find gut microbes can affect COVID vaccine response

byKarolinska InstitutetChanges in alpha diversity and bacterial genus from fecal samples collected at the baseline, to predict spike IgG titers in individuals. a Study design. b Alpha diversity
Gastroenterology January 24,2024
Researchers find gut microbes can affect COVID vaccine response

Researchers find gut microbes can affect COVID vaccine response

byKarolinska InstitutetChanges in alpha diversity and bacterial genus from fecal samples collected at the baseline, to predict spike IgG titers in individuals. a Study design. b Alpha diversity
Gastroenterology January 24,2024
Researchers identify why cancer immunotherapy can cause colitis

Researchers identify why cancer immunotherapy can cause colitis

by Nicole Fawcett,University of MichiganStudies in mice reveal the mechanism that induces this severe side effect and point to a solution that kills the cancer without causing gastrointestinal i
Gastroenterology January 24,2024
Researchers identify why cancer immunotherapy can cause colitis

Researchers identify why cancer immunotherapy can cause colitis

by Nicole Fawcett,University of MichiganStudies in mice reveal the mechanism that induces this severe side effect and point to a solution that kills the cancer without causing gastrointestinal i
Gastroenterology January 24,2024
Advanced neoplasia risk found to increase at upper range of negative FIT values

Advanced neoplasia risk found to increase at upper range of negative FIT values

by Elana GotkineIndividuals in the upper range of fecal immunochemical test (FIT)-negative screening have an increased risk for advanced neoplasia (AN), according to a research letter published online
Gastroenterology January 24,2024
Advanced neoplasia risk found to increase at upper range of negative FIT values

Advanced neoplasia risk found to increase at upper range of negative FIT values

by Elana GotkineIndividuals in the upper range of fecal immunochemical test (FIT)-negative screening have an increased risk for advanced neoplasia (AN), according to a research letter published online
Gastroenterology January 24,2024
FDA approves velsipity for moderate-to-severe ulcerative colitis in adults

FDA approves velsipity for moderate-to-severe ulcerative colitis in adults

FDA approves velsipity for moderate-to-severe ulcerative colitis in adultsby Lori SolomonThe U.S. Food and Drug Administration has approvedVelsipity(etrasimod) for adults with moderately t
Gastroenterology January 24,2024
FDA approves velsipity for moderate-to-severe ulcerative colitis in adults

FDA approves velsipity for moderate-to-severe ulcerative colitis in adults

FDA approves velsipity for moderate-to-severe ulcerative colitis in adultsby Lori SolomonThe U.S. Food and Drug Administration has approvedVelsipity(etrasimod) for adults with moderately t
Gastroenterology January 24,2024
Country of birth is a key factor in assessing risk for conditions favorable to stomach cancer development

Country of birth is a key factor in assessing risk for conditions favorable to stomach cancer development

Country of birth is a key factor in assessing risk for conditions favorable to stomach cancer developmentbyUniversity of Miami Leonard M. Miller School of MedicineCredit: Pixabay/CC0 Public Doma
Gastroenterology January 24,2024
Country of birth is a key factor in assessing risk for conditions favorable to stomach cancer development

Country of birth is a key factor in assessing risk for conditions favorable to stomach cancer development

Country of birth is a key factor in assessing risk for conditions favorable to stomach cancer developmentbyUniversity of Miami Leonard M. Miller School of MedicineCredit: Pixabay/CC0 Public Doma
Gastroenterology January 24,2024
More News
Week’s Top
Podcasts
... Preparing for a tough exam? A tough gym workout could help with your studies ... ... GOSH BRC Showcase 2025 - Genomic medicine ... ... Brain activity goes to extremes in soccer fans, neuroimaging reveals ...
FIND US ON
ABOUT
Who We Are
Contact Us
Editorial Team
Sitemap
Policy
Privacy Policy
Advertising Policy
Editorial Policy
Corrections Policy
Medical Disclaimer
Alliance
wmo.com
sleep.net
pharm.net
doctors.net
worldsleep.com